A new sensor, based on organic transistors, combines speed and accuracy in detecting single-molecule antigens belonging to the viruses that cause COVID-19 and MERS.

KAUST Distinguished Professor Pierre Magistretti, Director of the newly launched Smart-Health Initiative, took part in a virtual event put on by the U.S. Chamber of Commerce and the Kingdom of Saudi Arabia Ministry of Investment.

KAUST has recently launched a multidisciplinary scientific and clinical research and innovation health initiative dubbed the KAUST Smart-Health Initiative (SHI).

The Smart Health Initiative aims to enhance Saudi Arabia's capabilities in what Magistretti describes as precision medicine.

KAUST announced a collaboration with Janssen Pharmaceutical Companies of Johnson & Johnson to explore opportunities for research and innovation in the area of neglected tropical diseases, with a focus on dengue fever.

The COVID-19 pandemic has activated vital innovation and R&D initiatives to tackle the crippling effects, health ramifications, and overall impact of the coronavirus on global societies and economies.